Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lysozyme for Prevention of COPD Exacerbations
jRCT1080222006Phase 4
- Sponsor
- Eisai Co., Ltd.
- Start
- Jan 2013
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in chronic obstructive pulmonary disease (COPD) comparing Lysozyme hydrochloride with Placebo (2 arms).
02
Drugs
lysozyme
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on jRCT1080222006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222006.